Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01284296 · ClinicalTrials.gov registry record · NA
Comparison of Three Methods of Hemoglobin Monitoring
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01284296 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 20 participants.
The verdict
NCT01284296, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will further investigate the Masimo SpHb \[FDA Approved\] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digital block) of lidocaine (an FDA approved local anesthetic), and assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb).
Interventions
- DRUG Lidocaine digital block
- DEVICE Masimo SpHb continuous hemoglobin monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01284296
The ClinicalTrials.gov registry entry for NCT01284296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine digital block is the first listed.
NCT01284296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01284296 about?
NCT01284296 is a clinical study titled "Comparison of Three Methods of Hemoglobin Monitoring". This study will further investigate the Masimo SpHb \[FDA Approved\] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digita...
What is the current status of trial NCT01284296?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01284296?
The interventions under investigation include: Lidocaine digital block (DRUG), Masimo SpHb continuous hemoglobin monitor (DEVICE).
Who is sponsoring clinical trial NCT01284296?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.